Canine Blood Test

Article

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds, the company says.

In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease. NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states, the company adds.

For fastest response, visit

www.vdxinstitute.com

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.